NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

27 hedge funds and large institutions have $1.08M invested in NeuBase Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

70% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 10

Holders
27
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$311K
2
+$13K
3
+$7.56K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$1K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$997

Top Sellers

1
-$117K
2
-$25K
3
-$14.7K
4
State Street
State Street
Massachusetts
-$12.7K
5
Northern Trust
Northern Trust
Illinois
-$10.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$13
27
–
28
–
29
–
30
–
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
1
2